An update on Brexit and IP rights for pharmaceutical companies

Charlotte Tillett and Kate Maguire with S&B provide an update on where we are with Brexit and IP rights in the pharmaceutical sector.

Please see their recent article in Pharmaceutical Market Europe (PME).

Contact our experts for further advice

View profile for Charlotte TillettCharlotte Tillett, View profile for Kate MaguireKate Maguire

Search our site